Follow the people · Insider
Innovative Cellular Therapeutics Holdings Ltd
Innovative Cellular Therapeutics Holdings Ltd files insider transactions with the SEC as a 10% owner of Lyell Immunopharma (LYEL). We hold 2 disclosed purchases and sales filed since 18 June 2026, 2 of them in the last 90 days.
- Files forLYEL
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure27 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 15 June 2026 — 27 July 202610% owner · Lyell Immunopharma (LYEL)6 Form 4 lines · source: SEC Form 4
Everything they disclosed
6 entries, newest first — one per disclosure report, one per Form 4 line- acquired or disposed of, other 38,500 shares of Lyell ImmunopharmaSEC Form 427 July 2026Common Stock · traded 27 July 2026 · filed 27 July 2026
- acquired or disposed of, other 44,000 shares of Lyell ImmunopharmaSEC Form 427 July 2026Common Stock · traded 27 July 2026 · filed 27 July 2026
- ▼ sold on the open market 10 shares of Lyell ImmunopharmaSEC Form 420 July 2026Common Stock · traded 17 July 2026 · filed 20 July 2026
- ▼ sold on the open market 10 shares of Lyell ImmunopharmaSEC Form 417 July 2026Common Stock · traded 16 July 2026 · filed 17 July 2026
- acquired or disposed of, other 76,000 shares of Lyell ImmunopharmaSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- acquired or disposed of, other 66,500 shares of Lyell ImmunopharmaSEC Form 418 June 2026Common Stock · traded 15 June 2026 · filed 18 June 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.